Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
SRPT

Sarepta

$121.60

1.92 (1.60%)

09:16
04/17/19
04/17
09:16
04/17/19
09:16
Recommendations
Sarepta analyst commentary at BTIG »

Sarepta remains in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

SRPT

Sarepta

$120.49

-6.19 (-4.89%)

16:57
04/11/19
04/11
16:57
04/11/19
16:57
Initiation
Sarepta initiated at Evercore ISI »

Sarepta initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

BOLD

Audentes Therapeutics

$37.25

1.27 (3.53%)

, SRPT

Sarepta

$118.59

2.03 (1.74%)

05:24
03/29/19
03/29
05:24
03/29/19
05:24
Recommendations
Audentes Therapeutics, Sarepta analyst commentary at Piper Jaffray »

Piper believes Audentes…

BOLD

Audentes Therapeutics

$37.25

1.27 (3.53%)

SRPT

Sarepta

$118.59

2.03 (1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

SRPT

Sarepta

$119.35

2.79 (2.39%)

10:54
03/28/19
03/28
10:54
03/28/19
10:54
Recommendations
Sarepta analyst commentary at Piper Jaffray »

Sarepta price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

SRPT

Sarepta

$116.56

-5.37 (-4.40%)

08:37
03/28/19
03/28
08:37
03/28/19
08:37
Hot Stocks
Sarepta announces interim results from ESSENCE study »

Sarepta announced results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

SRPT

Sarepta

$118.97

-5.03 (-4.06%)

06:54
03/26/19
03/26
06:54
03/26/19
06:54
Recommendations
Sarepta analyst commentary at Citi »

Sarepta gene therapy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

SRPT

Sarepta

$118.22

-5.78 (-4.66%)

13:15
03/25/19
03/25
13:15
03/25/19
13:15
Recommendations
Sarepta analyst commentary at Piper Jaffray »

Piper stays bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 19

    Aug

SRPT

Sarepta

$118.24

-5.76 (-4.65%)

12:18
03/25/19
03/25
12:18
03/25/19
12:18
Recommendations
Sarepta analyst commentary at Needham »

Sarepta treatment shows…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 19

    Aug

SRPT

Sarepta

$119.44

-4.56 (-3.68%)

11:37
03/25/19
03/25
11:37
03/25/19
11:37
Recommendations
Sarepta analyst commentary at RBC Capital »

Sarepta data does not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 19

    Aug

SRPT

Sarepta

$115.65

-8.35 (-6.73%)

10:58
03/25/19
03/25
10:58
03/25/19
10:58
Recommendations
Sarepta analyst commentary at JPMorgan »

Data today reinforce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 19

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.